A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 47/42 (2006.01) A61K 9/00 (2006.01) A61K 31/135 (2006.01) A61K 31/215 (2006.01) A61K 31/505 (2006.01)
Patent
CA 2218037
Disclosed are proteinaceous compositions comprising collagen and an effective amount of a compatible cytotoxic drug which compositions are characterized by having a single collagen transition temperature of less than about 45 ~C. Such compositions possess enhanced retention of the cytotoxic drug at the site of injection and are optically translucent.
La présente invention concerne des compositions protéiniques comprenant du collagène et une quantité efficace d'un médicament cytotoxique compatible, ces compositions étant caractérisées par une température unique de transition du collagène inférieure à 45 ·C environ. De telles compositions, qui présentent une aptitude accrue à la rétention du médicament cytotoxique au niveau du site d'injection, sont optiquement translucides.
Jones Richard E.
Li Mike T.
Intarcia Therapeutics Inc.
Ledgley Law
Matrix Pharmaceutical Inc.
LandOfFree
Novel collagen formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel collagen formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel collagen formulations will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1788974